Back to Market Feed

INVOKANA 300 MG TABLET

canagliflozin
$19.1302per EA

Strength

300 mg/1

NDC

50458014130

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

CANAGLIFLOZIN

Approval Type

New Drug (NDA)

FDA Application

NDA204042

On Market Since

3/29/2013

Pharmacological Classes

P-Glycoprotein Inhibitors
Sodium-Glucose Cotransporter 2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

-0.1%

1Y

-0.1%

3Y

-0.1%

5Y

+10.1%

All

+124.8%

Generic Alternatives

1 alternative • Same active ingredient

INVOKANA 300 MG TABLET
Brand
50458014190•Janssen Pharmaceuticals Inc.
$19.1302

Related Drugs

Same classification

MYRBETRIQ ER 8 MG/ML SUSP
Brand
00469502099•Astellas Pharma US, Inc.
$2.2097
per ML
ZONISADE 100 MG/5 ML ORAL SUSP
Brand
52652800101•Azurity Pharmaceuticals Inc.
$2.7530
per ML
NEORAL 25 MG GELATIN CAPSULE
Brand
00078024615•Novartis Pharmaceuticals Corporation
$2.8879
per EA
KALETRA 80 MG-20 MG/ML SOLN
Brand
00074395646•AbbVie Inc.
$3.1186
per ML
SANDIMMUNE 25 MG CAPSULE
Brand
00078024015•Novartis Pharmaceuticals Corporation
$4.3773
per EA
SYNJARDY XR 12.5-1,000 MG TAB
Brand
00597030045•Boehringer Ingelheim Pharmaceuticals Inc.
$5.5938
per EA
SYNJARDY XR 12.5-1,000 MG TAB
Brand
00597030093•Boehringer Ingelheim Pharmaceuticals Inc.
$5.5938
per EA
SYNJARDY 12.5-1,000 MG TABLET
Brand
00597016818•Boehringer Ingelheim Pharmaceuticals Inc.
$5.6030
per EA
SYNJARDY 12.5-1,000 MG TABLET
Brand
00597016860•Boehringer Ingelheim Pharmaceuticals Inc.
$5.6030
per EA
SYNJARDY 5-1,000 MG TABLET
Brand
00597017518•Boehringer Ingelheim Pharmaceuticals Inc.
$5.6034
per EA